MAPK3 and SMAD1 take part in TGFbeta family signalling, which may be related to the healing of the damaged lung tissue and the consequent lung fibrosis, which has been reported in COVID-19 (17, 19). This evidence concerns the gene MAPK3 and COVID-19.